We are proud to announce that our CEO, Christer Nordstedt, will present Oblique Therapeutics activities at the Redeye January, 2024. The head of research, Olof Larsson CSO, and Jonas Ekblom, Chair of the Board, will also present and answer questions during the event.
Please contact business_development@obliquet.com for more information.
